Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for nasal congestion relief.

The U.S. Food and Drug Administration has approved the Sonu Band, an artificial intelligence-enabled, wearable medical device ...

The new funding will support MOS118 through its Phase II development while expanding Mosanna's product pipeline.

Firebrick Pharma Limited ( ($AU:FRE) ) just unveiled an update. Firebrick Pharma Limited announced the publication of its Phase 3 clinical trial ...